Insider Buy/Sell Details for the Healthcare Sector — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (5345)
EKSO BIONICS HOLDINGS, INC. (EKSO)
Wong Jerome — Chief Financial Officer
Shares
1,308
Price
$11.85
Total Value
$15.50K
Shares Held After
4,184
% of Holdings
31.3%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
272
Price
$99.05
Total Value
$26.94K
Shares Held After
73,631
% of Holdings
0.4%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
299
Price
$98.21
Total Value
$29.36K
Shares Held After
73,903
% of Holdings
0.4%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
460
Price
$97.33
Total Value
$44.77K
Shares Held After
74,202
% of Holdings
0.6%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
708
Price
$6.74
Total Value
$4.77K
Shares Held After
9,099
% of Holdings
7.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,766
Price
$13.92
Total Value
$108.07K
Shares Held After
232,699
% of Holdings
3.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
15,534
Price
$14.00
Total Value
$217.48K
Shares Held After
240,465
% of Holdings
6.1%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,767
Price
$13.92
Total Value
$108.09K
Shares Held After
255,999
% of Holdings
2.9%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
64,768
Price
$28.21
Total Value
$1.83M
Shares Held After
62,085
% of Holdings
51.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.41
Total Value
$255.59K
Shares Held After
503,596
% of Holdings
3.6%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
41,861
Price
$28.68
Total Value
$1.20M
Shares Held After
15,804
% of Holdings
72.6%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
3,961
Price
$37.77
Total Value
$149.61K
Shares Held After
112,018
% of Holdings
3.4%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
5,950
Price
$37.11
Total Value
$220.80K
Shares Held After
115,979
% of Holdings
4.9%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
15,886
Price
$50.49
Total Value
$802.08K
Shares Held After
17,044
% of Holdings
48.2%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
34,114
Price
$50.18
Total Value
$1.71M
Shares Held After
32,930
% of Holdings
50.9%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
9,440
Price
$72.77
Total Value
$686.90K
Shares Held After
92,832
% of Holdings
9.2%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
205,608
Price
$72.38
Total Value
$14.88M
Shares Held After
102,272
% of Holdings
66.8%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
450,000
Price
$5.00
Total Value
$2.25M
Shares Held After
0
% of Holdings
100.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
8,785
Price
$37.77
Total Value
$331.81K
Shares Held After
404,778
% of Holdings
2.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
13,196
Price
$37.11
Total Value
$489.70K
Shares Held After
413,563
% of Holdings
3.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
4,241
Price
$37.77
Total Value
$160.18K
Shares Held After
137,101
% of Holdings
3.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
6,371
Price
$37.11
Total Value
$236.43K
Shares Held After
141,342
% of Holdings
4.3%
WATERS CORP /DE/ (WAT)
Jiang Wei — Director
Shares
500
Price
$289.46
Total Value
$144.73K
Shares Held After
3,441
% of Holdings
14.5%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$5.84
Total Value
$243.33K
Shares Held After
1,816,448
% of Holdings
2.2%
Travere Therapeutics, Inc. (TVTX)
REED ELIZABETH E — Chief Legal Officer and GC
Shares
10,000
Price
$28.09
Total Value
$280.86K
Shares Held After
105,211
% of Holdings
8.7%
Privia Health Group, Inc. (PRVA)
Mehrotra Parth — Director
Shares
26,509
Price
$22.11
Total Value
$586.11K
Shares Held After
555,443
% of Holdings
4.6%
Allogene Therapeutics, Inc. (ALLO)
Beneski Benjamin Machinas — SVP, Chief Technical Officer
Shares
4,835
Price
$2.47
Total Value
$11.94K
Shares Held After
198,205
% of Holdings
2.4%
Allogene Therapeutics, Inc. (ALLO)
Chang David D — Director
Shares
47,763
Price
$2.47
Total Value
$117.97K
Shares Held After
5,150,599
% of Holdings
0.9%
DEXCOM INC (DXCM)
Brown Michael Jon — EVP, Chief Legal Officer
Shares
1,700
Price
$64.85
Total Value
$110.24K
Shares Held After
112,904
% of Holdings
1.5%
Opus Genetics, Inc. (IRD)
Jayagopal Ashwath — Chief Scientific & Dev. Ofc.
Shares
3,719
Price
$5.12
Total Value
$19.05K
Shares Held After
516,775
% of Holdings
0.7%
Opus Genetics, Inc. (IRD)
SCHACHLE JOSEPH K — Chief Operating Officer
Shares
3,719
Price
$5.25
Total Value
$19.53K
Shares Held After
300,781
% of Holdings
1.2%
Axogen, Inc. (AXGN)
DeVinney Erick Wayne — Chief Innovation Officer
Shares
5,221
Price
$32.84
Total Value
$171.46K
Shares Held After
262,781
% of Holdings
1.9%
Avalo Therapeutics, Inc. (AVTX)
Doyle Mittie — Chief Medical Officer
Shares
25,492
Price
$16.15
Total Value
$411.61K
Shares Held After
3,622
% of Holdings
87.6%
Privia Health Group, Inc. (PRVA)
Mountcastle David — EVP & Chief Financial Officer
Shares
6,391
Price
$22.11
Total Value
$141.31K
Shares Held After
220,413
% of Holdings
2.8%
Opus Genetics, Inc. (IRD)
Magrath George — Director
Shares
24,438
Price
$5.21
Total Value
$127.33K
Shares Held After
1,750,855
% of Holdings
1.4%
BIOCRYST PHARMACEUTICALS INC (BCRX)
Barnes Alane P — Chief Legal Officer
Shares
150,000
Price
$9.15
Total Value
$1.37M
Shares Held After
400,703
% of Holdings
27.2%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
493
Price
$69.75
Total Value
$34.39K
Shares Held After
116,332
% of Holdings
0.4%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
8,378
Price
$69.03
Total Value
$578.33K
Shares Held After
116,825
% of Holdings
6.7%
Tarsus Pharmaceuticals, Inc. (TARS)
LINK WILLIAM J PHD — Director
Shares
3,629
Price
$68.09
Total Value
$247.10K
Shares Held After
125,203
% of Holdings
2.8%
Opus Genetics, Inc. (IRD)
Zaremba Rabourn Amy — Head of Fin. Quality Assurance
Shares
2,816
Price
$5.25
Total Value
$14.77K
Shares Held After
190,312
% of Holdings
1.5%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
1,991
Price
$101.68
Total Value
$202.44K
Shares Held After
2,242,500
% of Holdings
0.1%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
3,009
Price
$101.18
Total Value
$304.45K
Shares Held After
2,244,491
% of Holdings
0.1%
HARVARD BIOSCIENCE INC (HBIO)
Snider William — Director
Shares
12,525
Price
$4.99
Total Value
$62.50K
Shares Held After
23,525
% of Holdings
53.2%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
6,000
Price
$15.16
Total Value
$90.96K
Shares Held After
2,112,777
% of Holdings
0.3%
ADMA BIOLOGICS, INC. (ADMA)
Grossman Adam S — Director
Shares
15,000
Price
$15.16
Total Value
$227.40K
Shares Held After
2,118,777
% of Holdings
0.7%
OMNICELL, INC. (OMCL)
Manley Corey J — EVP&CHIEF LEGAL/ADMIN OFFICER
Shares
7,405
Price
$34.69
Total Value
$256.88K
Shares Held After
96,717
% of Holdings
7.1%
Oruka Therapeutics, Inc. (ORKA)
Quinlan Paul T — General Counsel
Shares
733
Price
$41.30
Total Value
$30.27K
Shares Held After
31,767
% of Holdings
2.3%
Fortrea Holdings Inc. (FTRE)
Mcconnell Jill G. — Chief Financial Officer
Shares
1,804
Price
$9.22
Total Value
$16.63K
Shares Held After
72,276
% of Holdings
2.4%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
641
Price
$41.30
Total Value
$26.47K
Shares Held After
33,377
% of Holdings
1.9%
Oruka Therapeutics, Inc. (ORKA)
Goncalves Joana — Chief Medical Officer
Shares
1,177
Price
$41.94
Total Value
$49.36K
Shares Held After
34,018
% of Holdings
3.3%
Showing 401–450 of 5345 transactions (page 9 of 107)